TriMas (NASDAQ:TRS) Hits New 1-Year High – Should You Buy?

Shares of TriMas Co. (NASDAQ:TRS) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $28.11 and last traded at $28.00, with a volume of 1578394 shares. The stock had previously closed at $26.57.

Analyst Upgrades and Downgrades

Separately, BWS Financial reiterated a “buy” rating and set a $40.00 price target on shares of TriMas in a research report on Wednesday, October 9th.

TriMas Price Performance

The company has a debt-to-equity ratio of 0.63, a current ratio of 2.82 and a quick ratio of 1.48. The stock’s fifty day moving average is $25.07 and its 200-day moving average is $25.71. The stock has a market cap of $1.14 billion, a PE ratio of 28.67 and a beta of 0.67.

TriMas (NASDAQ:TRS) last announced its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.10). TriMas had a return on equity of 9.61% and a net margin of 4.44%. The firm had revenue of $240.50 million for the quarter, compared to analyst estimates of $238.63 million. During the same quarter in the prior year, the business earned $0.50 EPS. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. As a group, equities analysts anticipate that TriMas Co. will post 1.75 EPS for the current year.

TriMas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 13th. Shareholders of record on Tuesday, August 6th were given a $0.04 dividend. The ex-dividend date of this dividend was Tuesday, August 6th. This represents a $0.16 dividend on an annualized basis and a yield of 0.57%. TriMas’s dividend payout ratio is currently 16.33%.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of TRS. Vanguard Group Inc. lifted its holdings in shares of TriMas by 2.3% in the 1st quarter. Vanguard Group Inc. now owns 4,358,524 shares of the industrial products company’s stock worth $116,503,000 after acquiring an additional 100,068 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in TriMas by 0.8% during the first quarter. Allspring Global Investments Holdings LLC now owns 3,095,572 shares of the industrial products company’s stock worth $82,745,000 after purchasing an additional 25,795 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of TriMas by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 2,530,874 shares of the industrial products company’s stock worth $64,689,000 after buying an additional 19,436 shares during the period. Wellington Management Group LLP grew its stake in shares of TriMas by 1.5% in the fourth quarter. Wellington Management Group LLP now owns 2,393,786 shares of the industrial products company’s stock valued at $60,635,000 after buying an additional 34,596 shares in the last quarter. Finally, Kennedy Capital Management LLC raised its holdings in shares of TriMas by 197.8% in the 1st quarter. Kennedy Capital Management LLC now owns 273,200 shares of the industrial products company’s stock valued at $7,303,000 after buying an additional 181,447 shares during the period. Hedge funds and other institutional investors own 99.42% of the company’s stock.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.